Delivery Order SPE2DB22D2005-SPE2DB25FJSQ9
- Not listed
- The Defense Logistics Agency awarded a $1,002.95 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $1,207.19 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 30-gram units under a firm fixed-price contract with an ultimate completion date of September 23, 2025. This is a non-set-aside, competitively awarded delivery order executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in a 30-gram unit, with a contract value of $1,125.26. This is a firm fixed-price delivery order with no set-aside designation, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 100-gram quantities, with a ceiling value of $1,704.94. This contract, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, utilizes firm fixed-price pricing and was competitively awarded without set-aside provisions. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in a 30-gram quantity, valued at $20,510.86. This delivery order, issued on September 11, 2025, represents a firm fixed-price contract with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,557.56 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram quantities. This non-competitive, firm fixed-price delivery order was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.86 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram quantities. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 10, 2025, and represents a direct procurement from the prime contractor's established federal supply agreement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,484.65 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram quantities. This is a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, issued on October 27, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream (30gm) on September 8, 2025, with a ceiling value of $1,002.05. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and carries no set-aside designation. The contract was competitively awarded and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with the agency. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,887.66 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed price, non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSQ9Delivery Order
The Defense Logistics Agency awarded a $2,024.44 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 30-gram units, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and utilizes a child delivery order structure under AmerisourceBergen's larger contract vehicle with DLA. The product will be performed from the vendor's facility in Conshohocken, Pennsylvania, supporting federal medical procurement requirements for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a major pharmaceutical distributor within the Defense Health Agency supply chain, with delivery orders covering diverse therapeutic domains including specialty medications, generic drugs, vaccines, and specialized medical supplies across multiple customer bases including the U.S. Coast Guard and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/26/25 |